Latest News by Industry
ANI PHARMACEUTICALS INC [ANIP] has reported $486.8 million in revenue for year ended Dec 31, 2023.
Also Read: ANI: Q3 Earnings Snapshot
The company said in a filing before the Securities and Exchange Commission that its profit for the year was $18.8 million.
Also Read: ANI: Q1 Earnings Snapshot
Based in Baudette, Minnesota, ANI PHARMACEUTICALS INC operates in the Manufacturing sector.
Related Articles: ANI: Q4 Earnings Snapshot ANI Pharmaceuticals Announces the FDA Approval and Launch of Fluoxetine Oral Solution USP ANI Pharmaceuticals Announces the FDA Approval and Launch of Trimethoprim Tablets USP
USInMinutes/IndiaInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to more news alerts here. Although care is taken to ensure accuracy of the data, the article does not intend to replace user diligence while taking decisions of financial or legal implications